Results
1
High Growth Stocks
1 companies
argenx
Market Cap: €48.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€772.00
7D
1.6%
1Y
50.1%
